| scholarly article | Q13442814 |
| P50 | author | Neill J Liptrott | Q39489163 |
| Andrew Owen | Q39489259 | ||
| Jean G Sathish | Q58424510 | ||
| P2093 | author name string | D J Back | |
| S H Khoo | |||
| P G Bray | |||
| M Penny | |||
| P2860 | cites work | The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions | Q24310512 |
| Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin | Q28211706 | ||
| Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes | Q28239777 | ||
| Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes | Q28254139 | ||
| Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells | Q33202588 | ||
| P-glycoprotein in autoimmune diseases | Q33360575 | ||
| Microheterogeneity of alpha 1 acid glycoprotein in rheumatoid arthritis: dependent on disease duration? | Q33565293 | ||
| Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. | Q33981559 | ||
| Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis | Q34418159 | ||
| Secretion of peptides and proteins lacking hydrophobic signal sequences: the role of adenosine triphosphate-driven membrane translocators | Q35486614 | ||
| Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies | Q35549213 | ||
| Protein binding in antiretroviral therapies | Q35571186 | ||
| The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hyp | Q35636412 | ||
| Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug. | Q35637979 | ||
| Cytochrome P450 enzymes: novel options for cancer therapeutics. | Q35693756 | ||
| HIV-1 induced AIDS is an allergy and the allergen is the Shed gp120--a review, hypothesis, and implications | Q35841997 | ||
| Intracellular pharmacokinetics of antiretroviral agents | Q36054598 | ||
| Role of P-glycoprotein in statin drug interactions | Q36634221 | ||
| Cytokine gene polymorphisms, cancer susceptibility, and prognosis | Q36689627 | ||
| P-glycoprotein: so many ways to turn it on. | Q37044372 | ||
| Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons | Q37447683 | ||
| Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4. | Q37583423 | ||
| Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver | Q38322847 | ||
| CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. | Q39583317 | ||
| Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels | Q40177451 | ||
| Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5. | Q40282075 | ||
| Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. | Q41172472 | ||
| Effect of 5637-conditioned medium and recombinant cytokines on P-glycoprotein expression in a human GM-CSF-dependent leukemic myeloid cell line | Q41290791 | ||
| Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures | Q42459607 | ||
| Guide to Receptors and Channels (GRAC), 3rd edition | Q43088119 | ||
| Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines | Q44209336 | ||
| Variability in activity of hepatic CYP3A4 in patients infected with HIV. | Q44874904 | ||
| Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA. | Q45145266 | ||
| Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients | Q45229364 | ||
| Alterations in gastric acidity in patients infected with human immunodeficiency virus | Q45769106 | ||
| An assessment of P-glycoprotein expression and activity in peripheral blood lymphocytes of transplant candidates | Q46420437 | ||
| Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction | Q46616703 | ||
| Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP. | Q46801300 | ||
| Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes | Q46985668 | ||
| Counter-regulatory effects of procalcitonin and indoxyl sulphate on net albumin secretion by cultured rat hepatocytes | Q47924950 | ||
| Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines | Q48124580 | ||
| Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier | Q48355279 | ||
| P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation. | Q53954128 | ||
| High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia. | Q54194573 | ||
| Detection of ABCC2, CYP2B6 and CYP3A4 in human peripheral blood mononuclear cells using flow cytometry | Q58073774 | ||
| Detection and quantification of minority HIV isolates harbouring the D30N mutation by real-time PCR amplification | Q58073790 | ||
| Factors impacting the expression of membrane-bound proteins in lymphocytes from HIV-positive subjects | Q58073794 | ||
| Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver | Q60787038 | ||
| Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis | Q71160288 | ||
| Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis | Q72023236 | ||
| [Multi-drug resistance in the treatments of autoimmune diseases] | Q79317505 | ||
| Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer | Q80546801 | ||
| Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis | Q80693015 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 497-508 | |
| P577 | publication date | 2009-01-20 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC | |
| P478 | volume | 156 |
| Q37595188 | ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer |
| Q89441164 | Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats |
| Q36708715 | Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS |
| Q38409261 | Camellia sinensis in asymptomatic hyperuricemia: A meta-analysis of tea or tea extract effects on uric acid levels |
| Q28468505 | Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV Infection |
| Q28081272 | Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery |
| Q38514821 | Effect of cocoa products and flavanols on platelet aggregation in humans: a systematic review. |
| Q38087565 | Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans: a systematic review and meta-analysis. |
| Q42283286 | Effect of peginterferon alfa-2a (40KD) on cytochrome P450 isoenzyme activity |
| Q52677743 | Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab. |
| Q35016654 | Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction |
| Q40204531 | Hepatic organoids for microfluidic drug screening |
| Q35749503 | Immunological response as a source to variability in drug metabolism and transport |
| Q83496835 | Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period |
| Q37310533 | Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. |
| Q38740792 | Inflammation and pharmacokinetics: potential implications for HIV-infection |
| Q35708089 | Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings |
| Q37232200 | Interactions between tenofovir and nevirapine in CD4+ T cells and monocyte-derived macrophages restrict their intracellular accumulation. |
| Q38216941 | Interference of flavonoids with fluorescent intracellular probes: methodological implications in the evaluation of the oxidative burst by flow cytometry |
| Q38803026 | Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation |
| Q33862472 | Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans. |
| Q92053598 | Perturbation Theory Machine Learning Modeling of Immunotoxicity for Drugs Targeting Inflammatory Cytokines and Study of the Antimicrobial G1 Using Cytometric Bead Arrays |
| Q36694926 | Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate |
| Q56966090 | Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients |
| Q46169240 | Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation. |
| Q34529127 | Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir |
| Q44363021 | Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes |
| Q37604385 | Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines |
| Q34705514 | Schistosome ABC multidrug transporters: From pharmacology to physiology |
| Q28553833 | Staphylococcus aureus and Lipopolysaccharide Modulate Gene Expressions of Drug Transporters in Mouse Mammary Epithelial Cells Correlation to Inflammatory Biomarkers |
| Q38054629 | The generation, detection, and effects of reactive drug metabolites |
| Q35609414 | The human P-glycoprotein transporter enhances the type I interferon response to Listeria monocytogenes infection |
| Q37836908 | The role of cytokines in the regulation of drug disposition: extended functional pleiotropism? |
| Q40621078 | Therapeutic protein-drug interactions: plausible mechanisms and assessment strategies |
Search more.